The Randox Liquid Cardiac Controls Level 1, Level 2, and Level 3 are liquid controls containing B...

FDA Device Recall #Z-0762-2017 — Class II — September 16, 2016

Recall Summary

Recall Number Z-0762-2017
Classification Class II — Moderate risk
Date Initiated September 16, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Randox Laboratories
Location Antrim
Product Type Devices
Quantity 2817

Product Description

The Randox Liquid Cardiac Controls Level 1, Level 2, and Level 3 are liquid controls containing BNP, CK MB Mass, Digoxin, D-Dimer, Homocysteine, hsCRP, Myoglobin, NT-ProBNP, Troponin I, and Troponin T. They have been developed for use in the quality control of BNP, CK MB Mass, Digoxin, D-Dimer, Homocysteine, hsCRP, Myoglobin, NT-ProBNP, Troponin I, and Troponin T assays on various clinical chemistry and immunoassay systems. This in vitro diagnostic device is intended for prescription use only.

Reason for Recall

An internal real-time stability monitoring program revealed decreased recovery of myoglobin (-20% bias) for Randox Immunoturbidimetric and Siemens Centaur Classic methods and CKMB (-21% bias) for Roche e411, BioMerieux Vidas, and Siemens Centaur Classic methods.

Distribution Pattern

Worldwide Distribution - US Distribution.

Lot / Code Information

CQ5053 CQ5052

Other Recalls from Randox Laboratories

Recall # Classification Product Date
Z-1286-2023 Class II CRP Immunoturbidimetric reagent. Intended for t... Feb 1, 2023
Z-2059-2018 Class II RX Imola (RX4900) For Professional Use for t... May 4, 2018
Z-0969-2018 Class III Immunoassay Premium Controls (3x4x5mL and 12x5m... Aug 11, 2017
Z-0970-2018 Class III Immunoassay Premium Plus Controls (3x4x5mL and ... Aug 11, 2017
Z-2167-2017 Class III Liquid Urine Control Level 3 For Professiona... Apr 27, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.